{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:11:17Z","timestamp":1787008277017,"version":"build-2736575974"},"reference-count":40,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We aimed to examine the antipsychotics used by patients hospitalized in the child and youth inpatient service providing tertiary care to investigate whether there is a difference between admission and discharge, polypharmacy, which antipsychotics are used, and which psychotropics are used concomitant with antipsychotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Research data were collected retrospectively from all children and adolescents hospitalized in a child and adolescent psychiatry inpatient service in a university hospital in a 4-year period (2015\u20132019). The sociodemographic and clinical characteristics of the patients, the antipsychotics they used at admission and discharge, the other psychotropics concomitantly used with antipsychotics, and the side effects associated with antipsychotics during hospitalization were collected from the files of the 363 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Patients on antipsychotics increased 12.1% from hospitalization to discharge. Antipsychotic polypharmacy increased from 16.2% at admission to 30.7% at discharge. Logistic regression analysis was performed to investigate the factors affecting antipsychotic and antipsychotic polypharmacy. Self-harm, aggression\/violence, and extended hospitalization were factors associated with increased antipsychotic use. Psychotic symptoms, psychotic disorder, and extended hospitalization were factors associated with an increase in antipsychotic polypharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Understanding the factors that may cause antipsychotic use and polypharmacy in inpatient services in children and adolescents may prevent unnecessary drug use and long-term side effects that may occur due to these drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2022.0065","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T15:14:13Z","timestamp":1679411653000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-2565","authenticated-orcid":false,"given":"Ahmet","family":"B\u00fcber","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Pamukkale University, Denizli, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-8759","authenticated-orcid":false,"given":"Erdal G\u00f6rkem","family":"Gavcar","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, K\u0131r\u0131kkale Y\u00fcksek Ihtisas Hospital, K\u0131r\u0131kkale, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Ba\u015fay","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Pamukkale University, Denizli, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u015fen","family":"\u00dcnl\u00fc","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Pamukkale University, Denizli, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fcrge","family":"Kabuk\u00e7u Ba\u015fay","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Pamukkale University, Denizli, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"\u015eenol","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, Pamukkale University, Denizli, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40501-018-0137-1"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000190"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0B013E3182549259"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLINTHERA.2010.04.021"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/CAP.2006.16.273"},{"issue":"2","key":"e_1_3_3_7_1","first-page":"32","article-title":"Recommendations for pharmacological management of inpatient aggression in children and adolescents","volume":"7","author":"Deshmukh P","year":"2010","unstructured":"Deshmukh P, , Kulkarni G, , Barzman D. Recommendations for pharmacological management of inpatient aggression in children and adolescents. Psychiatry (Edgmont), 2010; 7(2):32.","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_3_3_8_1","unstructured":"Education Medicaid Integrity Contractor for the CMS and Education Medicaid Program Integrity. Atypical antipsychotic medications: Use in pediatric patients. 2015. Available from: https:\/\/www.cms.gov\/medicare-medicaid-coordination\/fraud-prevention\/medicaid-integrity-education\/pharmacy-education-materials\/downloads\/atyp-antipsych-pediatric-factsheet11-14.pdf [Last accessed: July 03 2022]."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2020.00263"},{"key":"e_1_3_3_10_1","unstructured":"Findling RL Drury SS Jensen PS et al. Practice parameter for the use of atypical antipsychotic medications in children and adolescents. American Academy of Child and Adolescent Psychiatry. 2011 Available from: https:\/\/www.aacap.org\/App_Themes\/AACAP\/docs\/practice_parameters\/Atypical_antipsychotic_Medications_Web.pdf [Last accessed: June 25 2022]."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCHRES.2012.03.018"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/S00213-021-05809-8"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.07.001"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedhc.2011.10.009"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0716-x"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796020000293"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-017-0192-1"},{"key":"e_1_3_3_18_1","first-page":"153","article-title":"Prescribing patterns in adolescent psychiatric practice: An important role of antipsychotics","author":"Ka\u0161telan A","year":"2019","unstructured":"Ka\u0161telan A, , Hladnik A, , Petri\u0107 D, et al. Prescribing patterns in adolescent psychiatric practice: An important role of antipsychotics. Psychiatr Danub, 2019;31(Suppl 2):153\u2013161.","journal-title":"Psychiatr Danub"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454604773840517"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/CAP.2017.0111"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454604773840535"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/CAP.2018.0139"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.J4351"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURONEURO.2016.07.001"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Ortiz G. Antipsychotic medication prescribing practices among children and adolescents discharged from state psychiatric hospitals. In: AACAP's 65th Annual Meeting. Seattle WA; 2018.","DOI":"10.1016\/j.jaac.2018.09.290"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.5455\/apd.184670"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/OXFORDJOURNALS.SCHBUL.A006913"},{"key":"e_1_3_3_28_1","unstructured":"Pillay J Boylan K Carrey N et al. First- and second-generation antipsychotics in children and young adults: Systematic review update. Agency for Healthcare Research and Quality (USA): Rockville MD; 2017."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3238\/ARZTEBL.2018.0023"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182a607dd"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1453"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0126"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114533599"},{"issue":"3","key":"e_1_3_3_34_1","article-title":"Medication use in a child and adolescent inpatient unit of a mental health hospital [in Turkish]","volume":"24","author":"\u015eent\u00fcrk Pilan B","year":"2017","unstructured":"\u015eent\u00fcrk Pilan B, , Bila\u00e7 \u00d6, Orhon Z, et al. Medication use in a child and adolescent inpatient unit of a mental health hospital [in Turkish]. Turk J Child Adolesc Ment Health, 2017; 24(3):207\u20132018.","journal-title":"Turk J Child Adolesc Ment Health"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.1001403"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2014.07.007"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712001320"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1371012"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00316"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2022.2042597"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000263"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2022.0065","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2022.0065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2022.0065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:56:35Z","timestamp":1777388195000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2022.0065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1089\/cap.2022.0065"],"URL":"https:\/\/doi.org\/10.1089\/cap.2022.0065","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}